Page last updated: 2024-09-05

roxifiban and Sensitivity and Specificity

roxifiban has been researched along with Sensitivity and Specificity in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boucher, RJ; Brockson, RW; Miyawa, JH; Williams, RC1
Billheimer, JT; Bradley, JD; Cromley, DA; Daly, RN; Dicker, IB; Godonis, HE; Gorko, MA; Grimminger, LC; He, B; Hollis, GF; Kieras, CJ; Pedicord, DL; Seiffert, D; Spitz, SM; Stern, AM; Thomas, BE; Wynn, R; Zolotarjova, NI1

Other Studies

2 other study(ies) available for roxifiban and Sensitivity and Specificity

ArticleYear
Optimization and validation of chiral high-performance liquid chromatographic method for analysis of a fibrinogen (gpIIb/IIIa) receptor antagonist.
    Journal of chromatography. A, 1999, Jun-04, Volume: 844, Issue:1-2

    Topics: Amidines; Chromatography, High Pressure Liquid; Fibrinolytic Agents; Isoxazoles; Orosomucoid; Platelet Glycoprotein GPIIb-IIIa Complex; Quality Control; Sensitivity and Specificity; Stereoisomerism

1999
Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediated.
    Blood, 2002, May-15, Volume: 99, Issue:10

    Topics: Administration, Oral; Amidines; Animals; Antibodies; Biological Availability; Clinical Trials, Phase II as Topic; Enzyme-Linked Immunosorbent Assay; Epitopes; Humans; Isoxazoles; Kinetics; Pan troglodytes; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Conformation; Sensitivity and Specificity; Thrombocytopenia

2002